Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Biond Biologics has entered into an exclusive worldwide license agreement with Sanofi for the development and commercialization of BND-22.
read more
Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.
The promotion expands Gold’s previous role as senior director of pharmaceutical development and new technology. Capabilities Gold will manage in his new ...
read more
Monday, November 06, 2017
The new study will focus on high-risk older adults to determine whether an investigational drug can prevent or delay the emergence of symptoms by combatting the accumulation of amyloid plaques.
read more
Friday, November 13, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury supply chain.
read more
Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced the appointment of Stewart Mitchell as site head of its new antibody-drug conjugate (ADC) facility in Deeside, UK. Dr Mitchell brings more than 25 ...
read more
Tuesday, November 21, 2017
Symcel has secured a Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.
read more
Wednesday, January 09, 2019
Selexis has signed additional CLAs with Agenus, an immuno-oncology company with a pipeline of immune-modulating antibodies, cancer vaccines, and adoptive cell therapies.
read more
Friday, December 06, 2019
Cambrex announced the completion of its previously announced sale to an affiliate of the Permira funds.
read more
Aceto has announced its acquisition of Syntor Fine Chemicals.
read more
SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer.
read more
Thursday, January 08, 2026
PharmaForceIQ announced its acquisition of Aktana, aligning its digital orchestration platform with an AI-driven field Next-Best-Action (NBA) platform.
read more
Monday, February 29, 2016
AstraZeneca has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialization rights in China to its calcium channel blocker, Plendil (felodipine).
read more
Meissa Vaccines a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, has entered into a manufacturing agreement with Exothera S.A., a Univercells company and full-service Contract Research Development ...
read more
Monday, December 14, 2020
Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea.
read more
Wednesday, December 08, 2021
Rho, a full-service contract research organization (CRO) announced that it has acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. ...
read more